These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7831574)
21. [Snake venom disintegrins: classification and therapeutic potential]. Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581 [TBL] [Abstract][Full Text] [Related]
22. Isolation of bothrasperin, a disintegrin with potent platelet aggregation inhibitory activity, from the venom of the snake Bothrops asper. Pinto A; Angulo Y; Jiménez R; Lomonte B Rev Biol Trop; 2003 Mar; 51(1):253-9. PubMed ID: 15162701 [TBL] [Abstract][Full Text] [Related]
23. Molecular cloning of albolatin, a novel snake venom metalloprotease from green pit viper (Trimeresurus albolabris), and expression of its disintegrin domain. Singhamatr P; Rojnuckarin P Toxicon; 2007 Dec; 50(8):1192-200. PubMed ID: 17870140 [TBL] [Abstract][Full Text] [Related]
24. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa]. Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599 [TBL] [Abstract][Full Text] [Related]
26. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis. Dennis MS; Carter P; Lazarus RA Proteins; 1993 Mar; 15(3):312-21. PubMed ID: 8456099 [TBL] [Abstract][Full Text] [Related]
27. What have snakes taught us about integrins? Huang TF Cell Mol Life Sci; 1998 Jun; 54(6):527-40. PubMed ID: 9676572 [TBL] [Abstract][Full Text] [Related]
28. Cloning and characterisation of three novel disintegrin precursors from the venoms of three Atheris species: Atheris chlorechis, Atheris nitschei and Atheris squamigera. Wang H; Chen X; Wang L; Chen W; Zhou M; Chen T; Shaw C Toxicon; 2013 Sep; 71():31-40. PubMed ID: 23732124 [TBL] [Abstract][Full Text] [Related]
29. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins. McDowell RS; Dennis MS; Louie A; Shuster M; Mulkerrin MG; Lazarus RA Biochemistry; 1992 May; 31(20):4766-72. PubMed ID: 1591238 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the cross-linking site of disintegrins albolabrin, bitistatin, echistatin, and eristostatin on isolated human platelet integrin GPIIb/IIIa. Calvete JJ; McLane MA; Stewart GJ; Niewiarowski S Biochem Biophys Res Commun; 1994 Jul; 202(1):135-40. PubMed ID: 8037704 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins. RGD-containing peptides from viper venoms. Musial J; Niewiarowski S; Rucinski B; Stewart GJ; Cook JJ; Williams JA; Edmunds LH Circulation; 1990 Jul; 82(1):261-73. PubMed ID: 2364514 [TBL] [Abstract][Full Text] [Related]
32. Ligands to the platelet fibrinogen receptor glycoprotein IIb-IIIa do not affect agonist-induced second messengers Ca2+ or cyclic AMP. Williams JA; Ashby B; Daniel JL Biochem J; 1990 Aug; 270(1):149-55. PubMed ID: 2168700 [TBL] [Abstract][Full Text] [Related]
33. Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets. McLane MA; Kowalska MA; Silver L; Shattil SJ; Niewiarowski S Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):429-36. PubMed ID: 8042985 [TBL] [Abstract][Full Text] [Related]
34. Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition. Pfaff M; McLane MA; Beviglia L; Niewiarowski S; Timpl R Cell Adhes Commun; 1994 Dec; 2(6):491-501. PubMed ID: 7538018 [TBL] [Abstract][Full Text] [Related]
35. Recombinant expression of mutants of the Frankenstein disintegrin, RTS-ocellatusin. Evidence for the independent origin of RGD and KTS/RTS disintegrins. Sanz-Soler R; Lorente C; Company B; Sanz L; Juárez P; Pérez A; Zhang Y; Jin Y; Chen R; Eble JA; Calvete JJ; Bolás G Toxicon; 2012 Sep; 60(4):665-75. PubMed ID: 22677804 [TBL] [Abstract][Full Text] [Related]
36. Primary structures of platelet aggregation inhibitors (disintegrins) autoproteolytically released from snake venom hemorrhagic metalloproteinases and new fluorogenic peptide substrates for these enzymes. Takeya H; Nishida S; Nishino N; Makinose Y; Omori-Satoh T; Nikai T; Sugihara H; Iwanaga S J Biochem; 1993 Apr; 113(4):473-83. PubMed ID: 8514736 [TBL] [Abstract][Full Text] [Related]
37. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent. Kuo YJ; Chung CH; Huang TF Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995 [TBL] [Abstract][Full Text] [Related]
38. Structural domains in venom proteins: evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Kini RM; Evans HJ Toxicon; 1992 Mar; 30(3):265-93. PubMed ID: 1529462 [TBL] [Abstract][Full Text] [Related]
39. Platelet alpha IIb beta 3: a pharmacological integrin as a target to design new molecules with antithrombotic activity. Marguerie G; Jarrin A; Andrieux A Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):253-4. PubMed ID: 7687771 [No Abstract] [Full Text] [Related]